Solara Active Pharma Sciences Ltd (SOLARA) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 541540 | NSE: SOLARA | Pharmaceuticals & Drugs | Small Cap

Solara Active Pharma Share Price

549.60 -0.75 -0.14%
as on 05-Dec'25 14:26

Solara Active Pharma Sciences Ltd (SOLARA) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 541540 | NSE: SOLARA | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Solara Active Pharma

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Solara Active Pharma Sciences stock performance -

Key Ratios
mw4me loader
P/E Ratio (CD):
413.58
Market Cap:
2,651 Cr.
52-wk low:
441.1
52-wk high:
813

Is Solara Active Pharma Sciences Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Solara Active Pharma: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Solara Active Pharma Sciences Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 0%0%2.2%10.4%11.7%15.3%-0.7%1.8%-17.3%6.1%-
Value Creation
Index
NANA-0.8-0.3-0.20.1-1.1-0.9-2.2-0.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 005211,3871,3221,6171,2681,4441,2891,2841,206
Sales YoY Gr.-NANA166.2%-4.7%22.3%-21.6%13.8%-10.7%-0.4%-
Adj EPS 002.226.438.156.7-15.3-5.8-111.5-0.21.3
YoY Gr.-NANA1087.8%44.4%48.9%-127%NANANA-
BVPS (₹) 00285.4303.8338.2406.5390.1383.8238.7271261.3
Adj Net
Profit
00673.8111221-59.6-22.6-435-0.96
Cash Flow from Ops. 0049.2166242155-242156109213-
Debt/CF from Ops. 0012.93.22.93.9-4.26.49.23.7-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA-0.6%0.4%-0.4%
Adj EPS NA-134.6%NANA
BVPSNA-4.3%-11.4%13.6%
Share Price - -14.1% 9.6% -31.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
000.88.610.916.5-3.8-1.5-35.8-0.10.5
Op. Profit
Mgn %
001216.619.8246.49.3-7.416.116.2
Net Profit
Mgn %
001.15.38.413.7-4.7-1.6-33.7-0.10.5
Debt to
Equity
000.80.60.70.40.70.71.10.70.1
Working Cap
Days
000163177178312310285221117
Cash Conv.
Cycle
00040647018919418197-23

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Solara Active Pharma Sciences Ltd.

Standalone Consolidated
TTM EPS (₹) 0.8 1.3
TTM Sales (₹ Cr.) 1,206 1,206
BVPS (₹.) 261.7 261.3
Reserves (₹ Cr.) 1,213 1,210
P/BV 2.10 2.11
PE 722.35 413.58
From the Market
52 Week Low / High (₹) 441.10 / 812.95
All Time Low / High (₹) 123.04 / 1713.61
Market Cap (₹ Cr.) 2,651
Equity (₹ Cr.) 48.2
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Solara Active Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *39.7943.4749.0647.9938.2838.0040.7434.6438.9535.32
* Pledged shares as % of Promoter's holding (%)

Valuation of Solara Active Pharma - Consolidated Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Solara Active Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales5211,3871,3221,6171,2681,4441,2891,284
Operating Expenses 4581,1661,0621,2311,1881,3101,3841,077
Manufacturing Costs79181172181194200233163
Material Costs272705599724654789805626
Employee Cost 69186204229236229244212
Other Costs 399487961049310377
Operating Profit 6222125938680134-95206
Operating Profit Margin (%) 12.0%15.9%19.6%23.9%6.3%9.3%-7.4%16.1%
Other Income 2122829202358
Interest 258278847590105115
Depreciation 34839410911211110399
Exceptional Items 0000-30-1900
Profit Before Tax 668115222-91-45-4881
Tax -0100-33-23790
Profit After Tax 667115221-58-22-5671
PAT Margin (%) 1.1%4.8%8.7%13.7%-4.6%-1.5%-44.0%0.0%
Adjusted EPS (₹)0.121.339.356.8-14.9-5.7-145.00.1
Dividend Payout Ratio (%)0%22%5%11%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 7648499851,5851,5241,4999321,091
Share Capital 2526273636363640
Reserves 7398249581,5491,4881,4638961,051
Minority Interest44442233
Debt573439587516893884866687
Long Term Debt243225233155283235106114
Short Term Debt330214354361610649760573
Trade Payables313244216309276306313249
Others Liabilities 167422361174195130237203
Total Liabilities 1,8211,9602,1532,5882,8902,8212,3512,232

Fixed Assets

Gross Block1,1001,3091,5811,6751,7601,8681,8761,896
Accumulated Depreciation36121213318429528611705
Net Fixed Assets 1,0631,1891,3681,3561,3321,3401,2661,191
CWIP 71404088239238256280
Investments 10000222
Inventories188214280295576558360318
Trade Receivables263289227484490537349327
Cash Equivalents 47765719947994
Others Assets 189151181166206137111110
Total Assets 1,8211,9602,1532,5882,8902,8212,3512,232

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 49166242155-242156109213
PBT 058115222-91-45-4881
Adjustment 63148168173181187406210
Changes in Working Capital -11-25-16-206-31411913
Tax Paid -3-14-24-33-18141-1
Cash Flow From Investing Activity -85-116-359-106-243-81-4-37
Capex -35-58-268-172-208-110-40-40
Net Investments 047-50500-100
Others -51-104-4115-3430373
Cash Flow From Financing Activity 68-239792334-113-106-180
Net Proceeds from Shares 04430298300159
Net Proceeds from Borrowing 532134-107169-62-114-36
Interest Paid -22-78-79-83-73-87-103-113
Dividend Paid 00-16-20-11000
Others 37-11128424637111-190
Net Cash Flow 3127-20142-151-38-0-4

Finance Ratio

PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)0.788.3212.4817.23-3.75-1.47-46.640.05
ROCE (%)2.2210.3811.7315.34-0.671.79-17.296.07
Asset Turnover Ratio0.290.730.640.680.460.510.50.56
PAT to CFO Conversion(x)8.172.482.10.7N/AN/AN/A213
Working Capital Days
Receivable Days18473718014013012596
Inventory Days13153686512514313096
Payable Days420144140132163135140164

Solara Active Pharma Sciences Ltd Stock News

Solara Active Pharma Sciences Ltd FAQs

The current trading price of Solara Active Pharma on 05-Dec-2025 14:26 is ₹549.6.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Solara Active Pharma stood at ₹2,651.
The latest P/E ratio of Solara Active Pharma as of 04-Dec-2025 is 722.4.
The latest P/B ratio of Solara Active Pharma as of 04-Dec-2025 is 2.10.
The 52-week high of Solara Active Pharma is ₹813.0 and the 52-week low is ₹441.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Solara Active Pharma is ₹1,206 ( Cr.) .

About Solara Active Pharma Sciences Ltd

Solara Active Pharma Sciences is a dynamic, entrepreneurial and customer-oriented API manufacturer. It has a legacy of over three decades and trace its origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd.

The company is poised to bridge the industry gap by delivering value-based products while maintaining focus on customer needs. It has hundreds of scientists working at its two R&D Centers and many API manufacturing facilities armed with global approvals and 2 dedicated R&D facilities. 

The company has a highly compliant manufacturing footprint spread over six large scale multi-product facilities. The company’s business is spread across several countries with extensive operations in the key markets of North America, Europe, Japan, South Korea and the Middle East and North Africa. 

Business area of the company

The company is a global, R&D focused, pureplay API company engaged in the manufacturing and development of APIs and offering Contract Manufacturing and Development Services for global companies. 

Products and services
  • Commercial and R&D products
  • Contract research and Manufacturing

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×